Novartis Acquires The Medicines Company For $9.7 Billion

Novartis acquires The Medicines Company for $9.7 billion

CNBC Television

Novartis buying Parsippany-based company for $9.7 billion

NJ Spotlight News

Strategy to become the most valued and trusted medicines company

The Medicines Company's Alex Denner on Novartis deal to buy the company

CNBC Television

Novartis Agrees to $6.8 Billion Medicines Co. Deal

Bloomberg Television

Novartis transformation into a pure-play Innovative Medicines company

Novartis generated $40 billion in innovative medicine sales, says CEO

CNBC Television

Novartis CEO: Spinoffs will see us succeed as a pure-play innovative medicines company

CNBC International News

Strengthening commercial and R&D in the US

Novartis agrees $9.7bn deal for US heart drug maker

Boyd Digital: Business News

Changing the paradigm in cardiovascular disease

John Maraganore on the ORION-11 Phase 3 Results

Alnylam Pharmaceuticals

Biotech's having a big day thanks to $9.7B acquisition by Novartis

CNBC Television

Novartis CEO on the company's pledge to provide no-profit medicines to low-income countries

CNBC International News

Novartis CEO: Our leukemia drug Scemblix is a potential $3 billion plus medicine

CNBC Television

Novartis CEO says FDA's extended approval of breast cancer drug is a 'landmark' for the firm

CNBC International News

Novartis CEO: Nations pulling back on health care spending ‘has long-term consequences'

Novartis ruling shows India doesn't want innovation: Peter Pitts

NDTV

Novartis CEO: Confident about continued sales growth for rest of year

CNBC International News

Novartis CEO: We expect our six key drugs to grow ahead of analyst expectations

CNBC Television